Finance

Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
$3.09
-1.90%
(-0.060) 1D
$3.08
-0.32% (-0.0100)
Pre-market
Closed: Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
$3.16
High
$3.20
Low
$3.05
Mkt. cap
71.13M
Avg. vol.
712.77K
Volume
0.00
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.30
Shares outstanding
26.28M
No. of employees
33
Open
$3.16
High
$3.20
Low
$3.05
Mkt. cap
71.13M
Avg. vol.
712.77K
Volume
0.00
52-wk high
$16.00
52-wk low
$2.66
EPS
-$2.41
Beta
1.30
Shares outstanding
26.28M
No. of employees
33
News stories
From web sources and news partners
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteelicio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELTX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current $3.09
$27.00 (+773.79%)
Average
$20.67 (+568.93%)
Lowest
$12.00 (+288.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
06/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$23.00
+644.3%
06/22/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$12.00
+288.3%
06/18/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$27.00
+773.8%
06/10/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$20.00
+547.2%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
$18.00
+482.5%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+450.2%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.04M
5.08M
6.76M
6.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.01M
3.76M
3.84M
3.62M
Operating expense
8.04M
8.84M
10.60M
10.43M
Total operating expenses
8.04M
8.84M
10.60M
10.43M
Operating income
-8.04M
-8.84M
-10.60M
-10.43M
Other non operating income
-1.81M
1.26M
-984.00K
2.48M
EBT including unusual items
-10.08M
-7.72M
-11.82M
-8.22M
EBT excluding unusual items
-10.08M
-7.72M
-11.82M
-8.22M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.08M
-7.72M
-11.82M
-8.22M
Net profit margin
-
-
-
-
Earnings per share
-0.60
-0.49
-0.65
-0.43
Interest and investment income
199.00K
199.00K
157.00K
138.00K
Interest expense
-426.00K
-337.00K
-407.00K
-410.00K
Net interest expenses
-227.00K
-138.00K
-250.00K
-272.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.00M
-8.79M
-10.56M
-10.39M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps